Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR Mutation
Clinical trial NCT01405079 · UNKNOWN
Trial details
- NCT number
- NCT01405079
- Sponsor
- Guangdong Association of Clinical Trials
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-19
- Primary completion
- 2017-03-01
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.